Establishment of immunoassay for detecting HPV16 E6 and E7 RNA

Scientific Reports
Sen DingPingping Shen

Abstract

Cervical carcinoma is the most prevalent malignancy second only to breast cancer among women worldwide. Since more than 99% of cervical cancers are caused by human papilloma virus (HPV), measurement of HPV (HPV test) was commonly used in screening risk and/or early stage of cervical cancer as well as assessing the efficacies of the treatments that can decrease the incidence of cervical cancer. Many approaches that diagnose HPV infections have been developed, while most of them have distinct shortcomings. We here established a novel immunoassay method in which the pairs of unlabeled DNA probes firstly bind to HPV16 E6 and E7 RNAs to form the DNA-RNA hybrids, and the hybrids will subsequently be identified by S9.6 antibody. The sensitivity of this highly specific method can reach ~0.923 pg/mL and ~0.424 pg/mL of in vitro transcribed HPV16 E6 and E7 RNA, respectively, and reverse transcription and polymerase chain reaction (PCR) amplification were no longer needed. Thus, our immunoassay approaches can precisely reflect the actually viral load that is related to the course of HPV infection. In addition, it has also fast and low cost characteristic feature.

References

Sep 15, 1979·Analytical Biochemistry·H Nakazato
Jan 1, 1977·Current Topics in Microbiology and Immunology·H zur Hausen
Jan 1, 1979·Journal of Immunological Methods·S AotsukaR Yokohari
Mar 1, 1992·Journal of Clinical Microbiology·D B Casebolt, C B Stephensen
Oct 1, 1992·Clinical Microbiology Reviews·M J Wolcott
May 1, 1986·Journal of Immunological Methods·S J BoguslawskiR J Carrico
May 15, 1974·International Journal of Cancer. Journal International Du Cancer·H zur HausenG W Bornkamm
Apr 3, 2001·International Journal of Cancer. Journal International Du Cancer·F LuftM von Knebel Doeberitz
Jun 5, 2002·Nature Reviews. Cancer·Harald zur Hausen
Feb 7, 2003·The New England Journal of Medicine·Nubia MuñozUNKNOWN International Agency for Research on Cancer Multicenter Cervical Cancer Study Group
Jun 9, 2004·Virology·Ethel-Michele de VilliersHarald zur Hausen
Mar 9, 2005·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Anco MolijnLeen-Jan van Doorn
Dec 23, 2006·Nature Reviews. Cancer·Ciaran B J WoodmanLawrence S Young
Jul 14, 2007·Disease Markers·Antoinette A T P BrinkChris J L M Meijer
Mar 28, 2008·Journal of the National Cancer Institute·Guglielmo RoncoUNKNOWN New Technologies for Cervical Cancer Screening Working Group
Oct 14, 2008·Vaccine·Patti E GravittCosette M Wheeler
Aug 11, 2009·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Shihai HuangKlara Abravaya
Nov 26, 2009·Carcinogenesis·Michael J ThunElizabeth M Ward
Jan 6, 2010·International Journal of Cancer. Journal International Du Cancer·Carol E LevinSue J Goldie
Oct 20, 2010·Expert Review of Anti-infective Therapy·Mario Poljak, Boštjan J Kocjan
Feb 26, 2011·American Journal of Clinical Pathology·Mark H StolerUNKNOWN ATHENA (Addressing THE Need for Advanced HPV Diagnostics) HPV Study Group
Mar 9, 2011·International Journal of Cancer. Journal International Du Cancer·Patti E GravittKeerti V Shah
Dec 5, 2012·Vaccine·John DoorbarMargaret A Stanley
Jun 21, 2013·Journal of Molecular Recognition : JMR·Damilola D PhillipsClinton E Leysath

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA
in vitro transcription
PCR
electrophoresis

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.